Parliament Workbench
Data: Motions & questions to 26 Nov 2026

General Question · S7O-00256 · Session 7

For what reason it took a year longer for Sparsentan and Kinpeygo to be approved for use by NHS Scotland in the treatment of kidney disease…

Oral Asked by Victor Currie Reform Lodged 16 Sep 2026

The question

To ask the Scottish Government for what reason it took a year longer for Sparsentan and Kinpeygo to be approved for use by NHS Scotland in the treatment of kidney disease than it did for them to be approved for use in England.

The answer

This is an oral question, answered in the chamber on 22 Sep 2026. The answer is in the Official Report, linked below.

In the Official Report

1 contribution mention S7O-00256
  1. 22 Sep 2026
    General Question Time
    Victor Currie Reform Meeting of the Parliament

    To ask the Scottish Government for what reason it took a year longer for sparsentan and Kinpeygo to be approved for use by NHS Scotland in the treatment of kidney disease than it did for them to be approved for use in England. (S7O-00256)I…